SNWV (SANUWAVE Health) Tariff Resilience Score: 5/10 (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SNWV SANUWAVE Health Inc SNWV
29 GF Score
Price $4.61
GF Value $12.85
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is SANUWAVE Health Tariff Resilience Score?

SANUWAVE Health SNWV -5.92% 29 Tariff Resilience Score is 5 as of Aug. 21, 2026. GuruFocus rates SNWV with a GF Score™ of 29/100 and a GF Value™ of $12.85 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 827 Medical Devices & Instruments companies, SANUWAVE Health ranks better than 79.2% on this metric.

SANUWAVE Health has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

SANUWAVE Health has SANUWAVE Health relies on international suppliers for medical device components, exposing it to tariff risks. Its global sales markets could also be affected by tariffs. The company may mitigate risks through alternative suppliers and pricing strategies, but remains moderately vulnerable.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes SANUWAVE Health might have Average Resilient.

SANUWAVE Health  (NAS:SNWV) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

SANUWAVE Health Tariff Resilience Score Related Terms

SNWV vs SRTS, COCH, ECOR: Tariff Resilience Score Comparison

For the Medical Devices subindustry, SANUWAVE Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SANUWAVE Health Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where SANUWAVE Health's Tariff Resilience Score falls into.


SNWV
29GF Score
SANUWAVE Health Inc SNWV
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
SANUWAVE Health (SNWV) has a Tariff Resilience Score of 5 as of Aug. 21, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, SANUWAVE Health ranks #172 out of 827 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is SANUWAVE Health's Tariff Resilience Score too high?
SANUWAVE Health's current Tariff Resilience Score is 5. Based on the distribution chart, SANUWAVE Health ranks #172 out of 827 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, SANUWAVE Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does SANUWAVE Health's Tariff Resilience Score compare to SRTS and COCH?
According to the Medical Devices & Instruments industry distribution chart, SANUWAVE Health ranks #172 out of 827 companies for Tariff Resilience Score. This places SANUWAVE Health in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. SANUWAVE Health's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SANUWAVE Health stock overvalued right now?
Based on GuruFocus' analysis, SANUWAVE Health (SNWV) is currently considered Possible Value Trap. The stock's GF Value™ is $12.85, compared to a current price of $4.61 — trading 64.1% below its estimated fair value. The current Tariff Resilience Score is 5. SANUWAVE Health's overall GF Score™ is 29/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For SANUWAVE Health (SNWV), the current Tariff Resilience Score is 5 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SANUWAVE Health (SNWV) Overvalued in 2026?

Based on GuruFocus' analysis, SANUWAVE Health stock appears to be undervalued. The current stock price of $4.61 is trading 64.1% below its estimated GF Value™ of $12.85. GuruFocus considers SANUWAVE Health to be Possible Value Trap.

Key valuation signals for SNWV:

  • Tariff Resilience Score: 5
  • GF Value™: $12.85 vs. price of $4.61 (64.1% below fair value)
  • GF Score™: 29/100 with 7 warning signs

No single metric tells the full story. See the SNWV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SANUWAVE Health Business Description

Address 9600 W. 76th Street, Suite 118, Eden Prairie, MN, USA, 55344
SANUWAVE Health Inc is a medical device company providing directed energy products into the wound care space. It is focused on the commercialization of its patented regenerative medicine utilizing noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. Sanuwave's patented, FDA-cleared, and commercialised product is the UltraMIST system, which is used to treat a variety of acute and chronic wounds using ultrasound technology. The company operates in one reportable segment, the design and sale of medical devices. Geographically, the company generates revenue mainly from the United States.
29GF Score

Get the complete analysis for SNWV

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.61
Price
$12.85
GF Value